GO
| HSI1 | 26,485.90 | 0.00 | -- |
| HSCEI1 | 9,355.97 | 0.00 | -- |
| Back Zoom + Zoom - Block Traded | |
|
Chairman Guo Guangchang: FOSUN INTL to Harness Global Industrial Advantages to Drive Frontier Innovation in CN
2025-11-06 10:21:51 FOSUN INTL (00656.HK) is participating in the China International Import Expo (CIIE) for eight years in a row. The company, alongside its overseas member enterprises and global partners, is showcasing innovative pharmaceuticals, high-end medical devices, and international collaboration achievements at the FOSUN PHARMA (02196.HK) booth in the medical devices and healthcare exhibition area. The products focus on core therapeutic areas such as oncology, immune inflammation, central nervous system, and nephrology. Guo Guangchang, Chairman of Fosun, stated that the CIIE has become a window for China to build a new development pattern, a platform for high-level opening-up, and an international public product shared globally. Looking ahead, innovation in the healthcare sector is expected to target unmet clinical needs, whereas Fosun will keep harnessing its global industrial advantages, integrate resources, and promote the implementation of more cutting-edge innovative technologies in China. ~ AASTOCKS Financial News Website: www.aastocks.com | |